VP
VERTEX PHARMACEUTICALS INC
VRTX· Health Care· BiotechnologyS&P 500
Close · 13/11/2026
538.60
1D
-0.74%52-week range
412.27 – 568.67
Volume
7,55,900.00
Price history
VRTX
15/10/2026 to 13/11/2026
O 542.12 H 543.73 L 536.12
1W-1.55%
1M+5.87%
3M+4.47%
6M+23.26%
1Y+24.05%
3Y+42.88%
5Y+179.28%
MAX+182.40%
Fundamentals
as of 13/11/2026- Market cap
- $136.56B
- Shares out
- 253.54M
- P/E (trailing)
- 34.35
- P/E (forward)
- 27.04
- EPS (trailing)
- 15.68
- Dividend yield
- 0.00%
- Beta
- 0.28
- Profit margin
- 30.70%
- P/B
- 6.53
- Return on equity
- 19.02%
SEC financial statements
66 quarterly and 18 annual periods through 30/09/2026.
Details
- Ticker
- VRTX
- Index
- SP500
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 13/11/2026.
Tracked by Congress
10 filers · 1 on watchlist · 7 buys · 11 sells · ?: 2 · D: 2 · R: 14
- 26/08/2026David J. TaylorSellVertex Pharmaceuticals Incorporated - Common Stock$1,001–$15,000
- 03/05/2024Thomas H TubervilleWSellVertex Pharmaceuticals Incorporated - Common Stock$1,001–$15,000
- 27/03/2026Alan ArmstrongBuyVertex Pharmaceuticals Incorporated - Common Stock$1,001–$15,000
- 29/01/2026David J. TaylorSellVertex Pharmaceuticals Incorporated - Common Stock$1,001–$15,000
- 23/10/2024Julia LetlowBuyVertex Pharmaceuticals Incorporated - Common Stock$1,001–$15,000
- 07/08/2025David J. TaylorBuyVertex Pharmaceuticals Incorporated - Common Stock$1,001–$15,000
- 11/06/2025Lisa McClainSellVertex Pharmaceuticals Incorporated - Common Stock$1,001–$15,000
- 10/06/2025Lisa McClainSell+Vertex Pharmaceuticals Incorporated - Common Stock$1,001–$15,000